Joseph P Hagan Regulus Therapeutics Inc. (RGLS) insider trading activity

Joseph P Hagan Transaction History

Date	Transaction	Value	Shares Traded	Form
Date	Transaction	Value	Shares Traded	Form
Dec 04 2020	BUY Grant, award, or other acquisition	$24,998 $0.63 p/Share	39,680

Also insider at

ZSANQ

Zosano Pharma Corp

Director

AUPH

Aurinia Pharmaceuticals Inc. Healthcare

Director

JPH

Joseph P Hagan

Chief Executive Officer

Victoria, A1

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGLS shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Regulus Therapeutics Inc. insider buys or sells RGLS shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to Regulus Therapeutics Inc.

Track Activities on RGLS

Account